[HTML][HTML] MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre, A Martínez… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
[PDF][PDF] MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre, A Martínez… - researchgate.net
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
[PDF][PDF] MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre, A Martínez… - pdfs.semanticscholar.org
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre Zapater… - Oncotarget, 2016 - ddd.uab.cat
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
[PDF][PDF] MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre, A Martínez… - scienceopen.com
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre… - …, 2016 - portalrecerca.uab.cat
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.
A Soriano, L París-Coderch, L Jubierre, A Martínez… - Oncotarget, 2016 - europepmc.org
Despite multimodal therapies, a high percentage of high-risk neuroblastoma (NB) become
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
refractory to current treatments, most of which interfere with cell cycle and DNA synthesis or …
[HTML][HTML] MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre, A Martínez… - Oncotarget, 2016 - oncotarget.com
Abstract Aroa Soriano 1, Laia París-Coderch 1, Luz Jubierre 1, Alba Martínez 2, Xiangyu
Zhou 3, Olga Piskareva 4, Isabella Bray 4, Isaac Vidal 1, Ana Almazán-Moga 1, Carla Molist …
Zhou 3, Olga Piskareva 4, Isabella Bray 4, Isaac Vidal 1, Ana Almazán-Moga 1, Carla Molist …
MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes
A Soriano, L París-Coderch, L Jubierre, A Martínez… - Oncotarget, 2016 - oncotarget.com
Abstract Aroa Soriano 1, Laia París-Coderch 1, Luz Jubierre 1, Alba Martínez 2, Xiangyu
Zhou 3, Olga Piskareva 4, Isabella Bray 4, Isaac Vidal 1, Ana Almazán-Moga 1, Carla Molist …
Zhou 3, Olga Piskareva 4, Isabella Bray 4, Isaac Vidal 1, Ana Almazán-Moga 1, Carla Molist …